4 news items
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
AMSC
AVGO
BITF
13 Jun 24
the Investigational New Drug Application and lifted the clinical hold on NPM-119.
NWTN Inc
Why GLP-1 Developer Vivani Medical's Stock Is Climbing
VANI
13 Jun 24
higher Thursday after the company announced the FDA cleared the Investigational New Drug application
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED)
VANI
13 Jun 24
. FDA has cleared its Investigational New Drug Application for NPM-119, paving the way for the commencement of the LIBERATE-1 Phase 1 trial
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
VANI
13 May 24
have initiated preclinical activities for NPM-115, our high-dose exenatide implant to support clinical investigations. An Investigational New Drug
- Prev
- 1
- Next